{"entity":{"type":"insider","cik":"0001276039","url":"/insider/0001276039","json_url":"/insider/0001276039.json","name":"TALLARIGO LORENZO","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":13,"first":"2005-03-03","last":"2014-07-09","span_basis":"filed_date"},"name_variants":[{"name":"TALLARIGO LORENZO","source":"filing","n_filings":13,"first_seen":"2005-03-03","last_seen":"2014-07-09"}],"transactions":[{"id":6282303,"accession":"0001144204-14-042176","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-042176","line_url":"/filing/0001144204-14-042176","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":243.055,"price_display":"243.06","price_state":"stated","total_value":486110.0,"total_display":"486,110.00","total_whole":"486,110","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-07","filed_date":"2014-07-09","scope":"insider","n_lines":2},{"id":6606424,"accession":"0001144204-14-029236","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-029236","line_url":"/filing/0001144204-14-029236#line-4","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":367.0,"shares_display":"367","price_per_share":232.0,"price_display":"232.00","price_state":"stated","total_value":85144.0,"total_display":"85,144.00","total_whole":"85,144","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-09","filed_date":"2014-05-09","scope":"insider"},{"id":6606417,"accession":"0001144204-14-029236","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-029236","line_url":"/filing/0001144204-14-029236","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1640.0,"shares_display":"1,640","price_per_share":259.7609756097561,"price_display":"259.76","price_state":"stated","total_value":426008.0,"total_display":"426,008.00","total_whole":"426,008","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-07","filed_date":"2014-05-09","scope":"insider","n_lines":2},{"id":7074392,"accession":"0001144204-14-022267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-022267","line_url":"/filing/0001144204-14-022267#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30623.0,"shares_display":"30,623","price_per_share":293.91,"price_display":"293.91","price_state":"stated","total_value":9000405.93,"total_display":"9,000,405.93","total_whole":"9,000,406","shares_owned_after":6454953.0,"shares_owned_after_display":"6,454,953","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-10","filed_date":"2014-04-11","scope":"insider"},{"id":7074391,"accession":"0001144204-14-022267","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-022267","line_url":"/filing/0001144204-14-022267#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318695.0,"shares_display":"318,695","price_per_share":320.0,"price_display":"320.00","price_state":"stated","total_value":101982400.0,"total_display":"101,982,400.00","total_whole":"101,982,400","shares_owned_after":5620195.0,"shares_owned_after_display":"5,620,195","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-09","filed_date":"2014-04-11","scope":"insider"},{"id":6606183,"accession":"0001144204-14-007725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-007725","line_url":"/filing/0001144204-14-007725#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":368.0,"shares_display":"368","price_per_share":354.52,"price_display":"354.52","price_state":"stated","total_value":130463.36,"total_display":"130,463.36","total_whole":"130,463","shares_owned_after":1640.0,"shares_owned_after_display":"1,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-10","filed_date":"2014-02-11","scope":"insider"},{"id":7074291,"accession":"0001144204-14-001504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-001504","line_url":"/filing/0001144204-14-001504#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1839.0,"shares_display":"1,839","price_per_share":67.41,"price_display":"67.41","price_state":"stated","total_value":123966.99,"total_display":"123,966.99","total_whole":"123,967","shares_owned_after":1640.0,"shares_owned_after_display":"1,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-07","filed_date":"2014-01-09","scope":"insider"},{"id":4443997,"accession":"0001144204-13-056563","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-056563","line_url":"/filing/0001144204-13-056563#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124912.0,"shares_display":"124,912","price_per_share":62.5,"price_display":"62.50","price_state":"stated","total_value":7807000.0,"total_display":"7,807,000.00","total_whole":"7,807,000","shares_owned_after":5938890.0,"shares_owned_after_display":"5,938,890","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-21","filed_date":"2013-10-23","scope":"insider"},{"id":4812501,"accession":"0001144204-13-055680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-055680","line_url":"/filing/0001144204-13-055680#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1123415.0,"shares_display":"1,123,415","price_per_share":62.5,"price_display":"62.50","price_state":"stated","total_value":70213437.5,"total_display":"70,213,437.50","total_whole":"70,213,438","shares_owned_after":6063802.0,"shares_owned_after_display":"6,063,802","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider"},{"id":2386675,"accession":"0001209191-08-014033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-014033","line_url":"/filing/0001209191-08-014033#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Officer (President, Internat'l Opers)","role_mark":"O","role_mark_label":"Officer (President, Internat'l Opers)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Internat'l Opers.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":51.5,"price_display":"51.50","price_state":"stated","total_value":515000.0,"total_display":"515,000.00","total_whole":"515,000","shares_owned_after":76105.0,"shares_owned_after_display":"76,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-26","filed_date":"2008-02-28","scope":"insider"},{"id":8085703,"accession":"0001209191-07-051786","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-07-051786","line_url":"/filing/0001209191-07-051786","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Officer (President, Internat'l Opers)","role_mark":"O","role_mark_label":"Officer (President, Internat'l Opers)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Internat'l Opers.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4533.0,"shares_display":"4,533","price_per_share":57.733677476285024,"price_display":"57.73","price_state":"stated","total_value":261706.76,"total_display":"261,706.76","total_whole":"261,707","shares_owned_after":70525.0,"shares_owned_after_display":"70,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-04","filed_date":"2007-09-04","scope":"insider","n_lines":5},{"id":7272605,"accession":"0001209191-07-034894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-034894","line_url":"/filing/0001209191-07-034894#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Officer (President, Internat'l Opers)","role_mark":"O","role_mark_label":"Officer (President, Internat'l Opers)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Internat'l Opers.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4533.0,"shares_display":"4,533","price_per_share":58.73,"price_display":"58.73","price_state":"stated","total_value":266223.09,"total_display":"266,223.09","total_whole":"266,223","shares_owned_after":75058.0,"shares_owned_after_display":"75,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7160931,"accession":"0001209191-07-023007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-023007","line_url":"/filing/0001209191-07-023007#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Officer (President, Internat'l Opers)","role_mark":"O","role_mark_label":"Officer (President, Internat'l Opers)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Internat'l Opers.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4533.0,"shares_display":"4,533","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":249315.0,"total_display":"249,315.00","total_whole":"249,315","shares_owned_after":79591.0,"shares_owned_after_display":"79,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-04","filed_date":"2007-04-09","scope":"insider"},{"id":3394589,"accession":"0001209191-06-055679","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-055679","line_url":"/filing/0001209191-06-055679","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Officer (President, Internat'l Opers)","role_mark":"O","role_mark_label":"Officer (President, Internat'l Opers)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Internat'l Opers.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5814.0,"shares_display":"5,814","price_per_share":56.95936016511868,"price_display":"56.96","price_state":"stated","total_value":331161.72,"total_display":"331,161.72","total_whole":"331,162","shares_owned_after":70127.0,"shares_owned_after_display":"70,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-20","filed_date":"2006-10-24","scope":"insider","n_lines":2},{"id":1658568,"accession":"0000059478-05-000079","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000059478-05-000079","line_url":"/filing/0000059478-05-000079#line-3","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Officer (President, Internat'l Opers)","role_mark":"O","role_mark_label":"Officer (President, Internat'l Opers)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Internat'l Opers.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":56.08,"price_display":"56.08","price_state":"stated","total_value":112160.0,"total_display":"112,160.00","total_whole":"112,160","shares_owned_after":54299.36,"shares_owned_after_display":"54,299.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-01","filed_date":"2005-03-03","scope":"insider"},{"id":1658566,"accession":"0000059478-05-000079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000059478-05-000079","line_url":"/filing/0000059478-05-000079#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001276039","owner_name":"TALLARIGO LORENZO","owner_display_name":"TALLARIGO LORENZO","owner_url":"/insider/0001276039","role":"Officer (President, Internat'l Opers)","role_mark":"O","role_mark_label":"Officer (President, Internat'l Opers)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Internat'l Opers.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":110000.0,"total_display":"110,000.00","total_whole":"110,000","shares_owned_after":54299.36,"shares_owned_after_display":"54,299.36","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-03","filed_date":"2005-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001270073","name":"INTERCEPT PHARMACEUTICALS INC","url":"/issuer/0001270073","role":"Director, Ten percent owner","n_filings":7,"first_seen":"2013-10-17","last_seen":"2014-07-09"},{"type":"issuer","type_label":"ISSUER","cik":"0000059478","name":"LILLY ELI & CO","url":"/issuer/0000059478","role":"Officer (President, Internat'l Opers)","n_filings":6,"first_seen":"2005-03-03","last_seen":"2008-02-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001276039","retrieved_at":"2026-08-24T22:47:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}